These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34732696)

  • 1. Engineered osteoclasts as living treatment materials for heterotopic ossification therapy.
    Jin W; Lin X; Pan H; Zhao C; Qiu P; Zhao R; Hu Z; Zhou Y; Wu H; Chen X; Ouyang H; Xie Z; Tang R
    Nat Commun; 2021 Nov; 12(1):6327. PubMed ID: 34732696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcified apoptotic vesicles from PROCR
    Yan J; Gao B; Wang C; Lu W; Qin W; Han X; Liu Y; Li T; Guo Z; Ye T; Wan Q; Xu H; Kang J; Lu N; Gao C; Qin Z; Yang C; Zheng J; Shen P; Niu L; Zou W; Jiao K
    J Extracell Vesicles; 2024 Apr; 13(4):e12425. PubMed ID: 38594791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice.
    Wang X; Li F; Xie L; Crane J; Zhen G; Mishina Y; Deng R; Gao B; Chen H; Liu S; Yang P; Gao M; Tu M; Wang Y; Wan M; Fan C; Cao X
    Nat Commun; 2018 Feb; 9(1):551. PubMed ID: 29416028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects, differential diagnosis and histogenesis of heterotopic ossification].
    Bosse A
    Veroff Pathol; 1997; 146():1-168. PubMed ID: 9123963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Bone-Cartilage-Stromal Progenitor Populations in Trauma Induced and Genetic Models of Heterotopic Ossification.
    Agarwal S; Loder SJ; Sorkin M; Li S; Shrestha S; Zhao B; Mishina Y; James AW; Levi B
    Stem Cells; 2016 Jun; 34(6):1692-701. PubMed ID: 27068890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Cells Isolated from Genetic and Trauma-Induced Heterotopic Ossification.
    Agarwal S; Drake J; Qureshi AT; Loder S; Li S; Shigemori K; Peterson J; Cholok D; Forsberg JA; Mishina Y; Davis TA; Levi B
    PLoS One; 2016; 11(8):e0156253. PubMed ID: 27494521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification.
    Bohner M; Maazouz Y; Ginebra MP; Habibovic P; Schoenecker JG; Seeherman H; van den Beucken JJJP; Witte F
    Acta Biomater; 2022 Jun; 145():1-24. PubMed ID: 35398267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-Derived Extracellular DNA Initiates Heterotopic Ossification.
    Han X; Gao C; Lu W; Yan J; Xu H; Guo Z; Qin W; Lu N; Gao J; Zhu W; Fu Y; Jiao K
    Inflammation; 2023 Dec; 46(6):2225-2240. PubMed ID: 37458919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of acquired heterotopic ossification: Risk factors, cellular mechanisms, and therapeutic implications.
    Cao G; Zhang S; Wang Y; Quan S; Yue C; Yao J; Alexander PG; Tan H
    Bone; 2023 Mar; 168():116655. PubMed ID: 36581258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence.
    Agarwal S; Loder S; Cholok D; Li J; Breuler C; Drake J; Brownley C; Peterson J; Li S; Levi B
    Stem Cells Transl Med; 2017 Mar; 6(3):799-806. PubMed ID: 28297577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice.
    Lee K; Kim H; Park HS; Kim KJ; Song H; Shin HI; Kim HS; Seo D; Kook H; Ko JH; Jeong D
    J Immunol; 2013 Feb; 190(4):1623-30. PubMed ID: 23303667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification.
    Molligan J; Mitchell R; Schon L; Achilefu S; Zahoor T; Cho Y; Loube J; Zhang Z
    Stem Cells Transl Med; 2016 Jun; 5(6):745-53. PubMed ID: 27112178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of heterotopic ossification-Molecular background and current treatment strategies.
    Łęgosz P; Drela K; Pulik Ł; Sarzyńska S; Małdyk P
    Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1229-1235. PubMed ID: 30144316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burn injury enhances bone formation in heterotopic ossification model.
    Peterson JR; De La Rosa S; Sun H; Eboda O; Cilwa KE; Donneys A; Morris M; Buchman SR; Cederna PS; Krebsbach PH; Wang SC; Levi B
    Ann Surg; 2014 May; 259(5):993-8. PubMed ID: 23673767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Survey of Cells Responsible for Heterotopic Ossification Development in Skeletal Muscles-Human and Mouse Models.
    Pulik Ł; Mierzejewski B; Ciemerych MA; Brzóska E; Łęgosz P
    Cells; 2020 May; 9(6):. PubMed ID: 32466405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular patterning in human heterotopic ossification.
    Cocks M; Mohan A; Meyers CA; Ding C; Levi B; McCarthy E; James AW
    Hum Pathol; 2017 May; 63():165-170. PubMed ID: 28315426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
    Sinha S; Uchibe K; Usami Y; Pacifici M; Iwamoto M
    Bone; 2016 Sep; 90():59-68. PubMed ID: 26891836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of the small proteoglycans decorin and proteoglycan-100 in heterotopic ossification.
    Bosse A; Kresse H; Schwarz K; Müller KM
    Calcif Tissue Int; 1994 Feb; 54(2):119-24. PubMed ID: 8012867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth.
    Touaitahuata H; Cres G; de Rossi S; Vives V; Blangy A
    Dev Biol; 2014 Sep; 393(1):57-70. PubMed ID: 24992711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.